Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: kha vu who wrote (22245)	1/17/1999 10:17:00 AM
From: Burjis S.	Read Replies (1) \| Respond to of 120523

LGND.... Unfortunately this stock has repeatedly disappointed, interest lasts for a few months the stock price rallies and then as usual this stock takes a nose dive! For me personally I would stay away until something concrete comes up look at the 3 yr chart on this one. IMNX now that was a different story, thanks for the ride from 52 to 143 in the past 4 mths even though I finally got off at 120(unfortunately sold my Jan calls)

To: kha vu who wrote (22245)	1/18/1999 1:54:00 AM
From: Street Walker	Read Replies (1) \| Respond to of 120523

LGND - treated investors badly in the past I had traded LGND right before their last FDA approval. When the approval was announced, the stock dropped significantly on the news. Traders remember these things about a stock and shy away, imo. If you can find other FDA pending stocks,or those nearing critical phase III trials, that are kind of underfollowed, with a low flash point, they would be more interesting. For example, check ou BIOMF, BMRA and GBFE. I am currently not invested in any of the above but do fit the criteria. My next short term stock pick (under $12) is going to be phenominal. Regards, S.W.